108 related articles for article (PubMed ID: 32864858)
1. A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer.
Poel D; Gootjes EC; Bakkerus L; Trypsteen W; Dekker H; van der Vliet HJ; van Grieken NCT; Verhoef C; Buffart TE; Verheul HMW
Cancer Med; 2020 Oct; 9(20):7558-7571. PubMed ID: 32864858
[TBL] [Abstract][Full Text] [Related]
2. miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial.
Anandappa G; Lampis A; Cunningham D; Khan KH; Kouvelakis K; Vlachogiannis G; Hedayat S; Tunariu N; Rao S; Watkins D; Starling N; Braconi C; Darvish-Damavandi M; Lote H; Thomas J; Peckitt C; Kalaitzaki R; Khan N; Fotiadis N; Rugge M; Begum R; Rana I; Bryant A; Hahne JC; Chau I; Fassan M; Valeri N
Clin Cancer Res; 2019 Jul; 25(13):3830-3838. PubMed ID: 30952636
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological utility of miR-203a-3p in diagnosing colorectal cancer.
Qasemi Rad M; Pouresmaeil V; Hosseini Mojahed F; Amirabadi A; Aalami AH
Mol Biol Rep; 2022 Jul; 49(7):6975-6985. PubMed ID: 35511316
[TBL] [Abstract][Full Text] [Related]
4. MiR-486-5p Downregulation Marks an Early Event in Colorectal Carcinogenesis.
Kelley KA; Wieghard N; Chin Y; Potter A; Mori M; Wong MH; Chin K; Tsikitis VL
Dis Colon Rectum; 2018 Nov; 61(11):1290-1296. PubMed ID: 30239392
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiling in tears and blood as predictive biomarkers for anti-VEGF treatment response in wet age-related macular degeneration.
Yen CY; Chiu CM; Fang IM
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; ():. PubMed ID: 38581435
[TBL] [Abstract][Full Text] [Related]
6. Expression Patterns of miRNA-423-5p in the Serum and Pericardial Fluid in Patients Undergoing Cardiac Surgery.
Miyamoto S; Usami S; Kuwabara Y; Horie T; Baba O; Hakuno D; Nakashima Y; Nishiga M; Izuhara M; Nakao T; Nishino T; Ide Y; Nakazeki F; Wang J; Ueyama K; Kimura T; Ono K
PLoS One; 2015; 10(11):e0142904. PubMed ID: 26562412
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosis.
Geiger L; Orsi G; Cseh T; Gombos K; Illés Z; Czéh B
Front Mol Neurosci; 2023; 16():1173212. PubMed ID: 37881368
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of miR-141-5p as a biomarker in the serum of patients with early spontaneous abortion.
Che X; Wang X; Wang L; Xu L; Zou L; Ma T; Chen B
Clinics (Sao Paulo); 2024; 79():100327. PubMed ID: 38330788
[TBL] [Abstract][Full Text] [Related]
9. Application Value of Combined Detection of miR-208 and miR-92a in Early Diagnosis of Myocardial Infarction.
Zhi S; Liu G; Ding Y; Wu W; Zhang Y; Yao H; Liu J; Li W
Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37917896
[TBL] [Abstract][Full Text] [Related]
10. Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer.
Poel D; Rustenburg F; Sie D; van Essen HF; Eijk PP; Bloemena E; Elhorst Benites T; van den Berg MC; Vergeer MR; Leemans RC; Buffart TE; Ylstra B; Brakenhoff RH; Verheul HM; Voortman J
Oral Oncol; 2020 Jun; 109():104851. PubMed ID: 32585557
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of miR-335-5p in People with Obesity and its Predictive Value for Metabolic Syndrome.
Liting L; Yufeng H
Horm Metab Res; 2024 Mar; ():. PubMed ID: 38447950
[TBL] [Abstract][Full Text] [Related]
12. Effects of High-Flux Dialysis Combined with Hemoperfusion on Serum GRP78 and miR-495-3p in Renal Failure Patients.
Fan W; Li X; Xu X; Chu H
Biomed Res Int; 2021; 2021():9591177. PubMed ID: 34671680
[TBL] [Abstract][Full Text] [Related]
13. Circulating miRNA-21 Levels in Breast Cancer Patients Before and After Chemotherapy and Its Association with Clinical Improvement.
Sukhija S; Purohit P; Pareek P; Garg PK; Vishnoi JR; Elhence PA; Varthya SB; Sharma P; Ambwani S; Charan J
Indian J Clin Biochem; 2024 Apr; 39(2):214-220. PubMed ID: 38577141
[TBL] [Abstract][Full Text] [Related]
14. Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Russo V; Lallo E; Munnia A; Spedicato M; Messerini L; D'Aurizio R; Ceroni EG; Brunelli G; Galvano A; Russo A; Landini I; Nobili S; Ceppi M; Bruzzone M; Cianchi F; Staderini F; Roselli M; Riondino S; Ferroni P; Guadagni F; Mini E; Peluso M
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011003
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Expression Level of miR-3135b-5p in Blood Samples of Breast Cancer Patients Experiencing Chemotherapy-Induced Cardiotoxicity.
Zare N; Dana N; Mosayebi A; Vaseghi G; Javanmard SH
Indian J Clin Biochem; 2023 Oct; 38(4):536-540. PubMed ID: 37746544
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Expression Profile in Patients Admitted to ICU as Novel and Reliable Approach for Diagnostic and Therapeutic Purposes.
Yan Y; Liao L
Mol Biotechnol; 2024 Jun; 66(6):1357-1375. PubMed ID: 37314613
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA test to identify individuals with high risk of colorectal cancer: abridged secondary publication.
Foo CC; Wong CKH; Law WL; Lam CLK; Leung WK; Ng L
Hong Kong Med J; 2023 Dec; 29 Suppl 7(6):14-17. PubMed ID: 38148650
[No Abstract] [Full Text] [Related]
18. FOLFIRINOX De-Escalation in Advanced Pancreatic Cancer: A Multicenter Real-Life Study.
Chevalier H; Vienot A; Lièvre A; Edeline J; El Hajbi F; Peugniez C; Vernerey D; Meurisse A; Hammel P; Neuzillet C; Borg C; Turpin A
Oncologist; 2020 Nov; 25(11):e1701-e1710. PubMed ID: 32886823
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of modified bevacizumab-XELOX therapy in Japanese patients with stage IV recurrent or non-resectable colorectal cancer.
Yokoyama D; Mukai M; Uda S; Kishima K; Koike T; Hasegawa S; Izumi H; Yamamoto S; Tajima T; Nomura E; Makuuchi H
J Gastrointest Oncol; 2021 Apr; 12(2):527-534. PubMed ID: 34012646
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology-based evaluation of natural compounds with paclitaxel for the treatment of metastatic breast cancer.
Rathaur P; Soni MN; Gelat B; Rawal R; Pandya HA; Johar K
Toxicol Appl Pharmacol; 2021 Jul; 423():115576. PubMed ID: 34000264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
